Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial-Reference-Cited by-同舟云学术

Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial

Published:2024-09-12 Issue:1 Volume:24 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Zhao Heng,Meng Wanting,Lv Xing,Li Jing,Cai Zhigui,Guo Xingxing,Wang Zifeng,Guo Li,Rong Mingzhe,Shen Cong,Liu Dingxin,Song Liqiang

Funder

The Key projects of basic research of natural science in Shaanxi Province

The Discipline Promotion Plan of Xijing Hospital

The Clinical Research Program of Air Force Military Medical University

The Shaanxi Provincial Health Scientific Research Fund Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12879-024-09886-w.pdf

Reference49 articles.

1. Ng TI, Correia I, Seagal J, DeGoey DA, Schrimpf MR, Hardee DJ, Noey EL, Kati WM. Antiviral drug discovery for the treatment of COVID-19 infections. Viruses-Basel. 2022;14(5):961.

2. Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374(6575):1586–1593.

3. Kabinger F, Stiller C, Schmitzová J, Dienemann C, Kokic G, Hillen HS, Höbartner C, Cramer P. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28(9):740–6.

4. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Simón-Campos A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. New Engl J Med. 2022;386(15):1397–408.

5. Jayk Bernal A, Gomes Da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. New Engl J Med. 2022;386(6):509–20.